Polyethylene Glycol 3350 Powder For Oral Solution 17G Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Polyethylene Glycol 3350: Powder for oral solution (17g)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file default-drug-image.png
PEG-3350 Pwd for Soln
Drug Image file default-drug-image.png
PEG-3350 Pwd for Soln
Drug Image file default-drug-image.png
PEG-3350 Pwd for Soln
Drug Image file default-drug-image.png
PEG-3350 Pwd for Soln
Drug Image file default-drug-image.png
PEG-3350 Pwd for Soln

What is this Medicine?

POLYETHYLENE GLYCOL 3350 (pol ee ETH i leen; GLYE col) powder is a laxative used to treat constipation. It increases the amount of water in the stool. Bowel movements become easier and more frequent.

CVS Pharmacy Patient Statistics for Polyethylene Glycol 3350: Powder for oral solution(17g)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Polyethylene Glycol 3350 Powder for Solution

NDC: 005740412
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Constipation

Sometimes used for but not FDA approved for the following conditions:
Fecal Impaction, Bowel Preparation

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Polyethylene Glycol 3350 Powder for Solution
Close All Sections Show

Reported Side Effects for Polyethylene Glycol 3350 Powder for Solution

Close Show
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Runny Nose Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Fecal Incontinence Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Fecal Urgency Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Polyethylene Glycol 3350

Close Show

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.